Journal article
Pediatric Pulmonology 2023 year in review: Rare and diffuse lung disease
Pediatric pulmonology, Vol.59(10), pp.2428-2434
10/2024
DOI: 10.1002/ppul.27108
PMID: 38818884
Appears in UI Libraries Support Open Access
Abstract
The field of pediatric rare and diffuse lung disease continues its maturation as research advances the understanding of diagnosis and treatment of children's interstitial lung disease, noncystic fibrosis bronchiectasis, and primary ciliary dyskinesia. The rarity and breadth of these conditions make them challenging to study, yet we continue to make progress in our understanding of pathophysiology, genotype/phenotype relationships, and treatment. Papers published on these topics in Pediatric Pulmonology and other journals in 2023 describe the power of multicenter cooperation and patient registries, enhance our understanding of pathophysiology and genotype/phenotype relationships, and report progress in treatments. In this review, we hope to increase awareness and knowledge of these conditions and to inspire future research.
Details
- Title: Subtitle
- Pediatric Pulmonology 2023 year in review: Rare and diffuse lung disease
- Creators
- Daniel M Hinds - University of IowaRebekah J Nevel - University of Missouri Women's and Children's HospitalDeborah R Liptzin - University of WashingtonAndrew T Barber - Virginia Commonwealth University
- Resource Type
- Journal article
- Publication Details
- Pediatric pulmonology, Vol.59(10), pp.2428-2434
- Publisher
- Wiley
- DOI
- 10.1002/ppul.27108
- PMID
- 38818884
- eISSN
- 1099-0496
- Language
- English
- Electronic publication date
- 05/31/2024
- Date published
- 10/2024
- Academic Unit
- Pulmonary Medicine; Stead Family Department of Pediatrics
- Record Identifier
- 9984635157302771
Metrics
8 Record Views